Testing for Hepatitis A
To test for hepatitis A, order IgM anti-HAV antibody testing on a serum or plasma sample as the primary diagnostic test for acute infection.
Diagnostic Testing Algorithm
Primary Test
- IgM anti-HAV antibody: The gold standard test for diagnosing acute hepatitis A infection 1
- Specimen: Serum or plasma (collected in clot tube, SST, EDTA, or PPT)
- Transport: Room temperature, within 2 hours 1
Interpretation of IgM anti-HAV Results
- Positive: Indicates acute or recent hepatitis A infection
- Negative: No evidence of acute hepatitis A infection
Additional Testing (if clinically indicated)
- Total anti-HAV antibody (IgG and IgM): To determine immune status or past infection
- Positive with negative IgM anti-HAV indicates past infection or immunity
- Negative indicates susceptibility to hepatitis A
Clinical Considerations
When to Test for Hepatitis A
- Patients with symptoms of acute hepatitis (jaundice, elevated liver enzymes, fatigue)
- Individuals with known exposure to hepatitis A
- During outbreaks of hepatitis A
- Evaluation of abnormal liver function tests
Potential Pitfalls
False-positive IgM results: May occur in populations with low prevalence of acute hepatitis A 4
- Consider clinical presentation when interpreting results
- IgG avidity testing may help differentiate true acute infection from false positives 5
Prolonged IgM persistence: IgM anti-HAV can remain positive beyond the acute phase
Testing too early: IgM anti-HAV may not be detectable in very early infection
- If high clinical suspicion and negative result, consider repeat testing in 1-2 weeks
Documentation and Follow-up
- Document hepatitis A immunity status in the patient's medical record
- For patients with acute hepatitis A, monitor liver function tests until normalized
- Consider testing for other hepatitis viruses (B and C) if clinically indicated
- No specific follow-up testing for hepatitis A is needed after resolution unless new symptoms develop
By following this testing approach, you can accurately diagnose acute hepatitis A infection and distinguish it from past infection or immunity, allowing for appropriate clinical management and public health interventions.